Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034650313> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2034650313 endingPage "741" @default.
- W2034650313 startingPage "735" @default.
- W2034650313 abstract "External quality assurance programs show the Nijmegen Bethesda Assay for FVIII inhibitors improves test specificity compared to the Classic Bethesda Assay but its uptake has been slow possibly due to the cost of using FVIII deficient plasma as diluent. This study was conducted to determine if modifying the Nijmegen Bethesda assay by replacement of FVIII deficient plasma with 4% as a diluent would be suitable for for measuring FVIII inhibitors.The titres of 59 samples from 35 patients with FVIII inhibitors were determined in parallel tests by the Nijmegen Bethesda Assay and and the modified Nijmegen assay. Method reproducibility was assessed on inhibitor-containing samples from seven individuals covering a range of titres from 1-200 Bethesda units/mL.The all-sample geometric mean titre was 6.73 Bethesda units/mL for the Nijmegen Bethesda Assay and 7.54 Bethesda units/mL for the modified Nijmegen assay. No sample was found where a difference in measured titre between methods would have altered clinical management. Agreement was very close in samples with titres less than 2BU/mL. Both assays gave inhibitor titres in external quality assurance samples of close to consensus values. The average between-run coefficients of variation were 8.6% for the Nijmegen Bethesda Assay and 7.9% for the modified Nijmegen assay.The modified Nijmegen assay using 4% albumin as the sample diluent showed good overall comparability to our existing Nijmegen Bethesda Assay and is substantially more cost-effective, making it a reasonable alternative for measuring FVIII inhibitors." @default.
- W2034650313 created "2016-06-24" @default.
- W2034650313 creator A5015182161 @default.
- W2034650313 creator A5028312991 @default.
- W2034650313 creator A5038387886 @default.
- W2034650313 creator A5057006053 @default.
- W2034650313 date "2013-12-01" @default.
- W2034650313 modified "2023-09-27" @default.
- W2034650313 title "Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors" @default.
- W2034650313 cites W1585450692 @default.
- W2034650313 cites W1604069935 @default.
- W2034650313 cites W1778397956 @default.
- W2034650313 cites W1849684651 @default.
- W2034650313 cites W1992454739 @default.
- W2034650313 cites W2018610797 @default.
- W2034650313 cites W2051560604 @default.
- W2034650313 cites W2062659221 @default.
- W2034650313 cites W2149564822 @default.
- W2034650313 cites W2187979857 @default.
- W2034650313 cites W2414551219 @default.
- W2034650313 doi "https://doi.org/10.1016/j.thromres.2013.09.018" @default.
- W2034650313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24119613" @default.
- W2034650313 hasPublicationYear "2013" @default.
- W2034650313 type Work @default.
- W2034650313 sameAs 2034650313 @default.
- W2034650313 citedByCount "9" @default.
- W2034650313 countsByYear W20346503132015 @default.
- W2034650313 countsByYear W20346503132017 @default.
- W2034650313 countsByYear W20346503132018 @default.
- W2034650313 countsByYear W20346503132020 @default.
- W2034650313 countsByYear W20346503132022 @default.
- W2034650313 countsByYear W20346503132023 @default.
- W2034650313 crossrefType "journal-article" @default.
- W2034650313 hasAuthorship W2034650313A5015182161 @default.
- W2034650313 hasAuthorship W2034650313A5028312991 @default.
- W2034650313 hasAuthorship W2034650313A5038387886 @default.
- W2034650313 hasAuthorship W2034650313A5057006053 @default.
- W2034650313 hasConcept C143425029 @default.
- W2034650313 hasConcept C153911025 @default.
- W2034650313 hasConcept C159654299 @default.
- W2034650313 hasConcept C185592680 @default.
- W2034650313 hasConcept C203014093 @default.
- W2034650313 hasConcept C2777136964 @default.
- W2034650313 hasConcept C2779486608 @default.
- W2034650313 hasConcept C32611913 @default.
- W2034650313 hasConcept C552990157 @default.
- W2034650313 hasConcept C55493867 @default.
- W2034650313 hasConcept C71924100 @default.
- W2034650313 hasConcept C86803240 @default.
- W2034650313 hasConceptScore W2034650313C143425029 @default.
- W2034650313 hasConceptScore W2034650313C153911025 @default.
- W2034650313 hasConceptScore W2034650313C159654299 @default.
- W2034650313 hasConceptScore W2034650313C185592680 @default.
- W2034650313 hasConceptScore W2034650313C203014093 @default.
- W2034650313 hasConceptScore W2034650313C2777136964 @default.
- W2034650313 hasConceptScore W2034650313C2779486608 @default.
- W2034650313 hasConceptScore W2034650313C32611913 @default.
- W2034650313 hasConceptScore W2034650313C552990157 @default.
- W2034650313 hasConceptScore W2034650313C55493867 @default.
- W2034650313 hasConceptScore W2034650313C71924100 @default.
- W2034650313 hasConceptScore W2034650313C86803240 @default.
- W2034650313 hasIssue "6" @default.
- W2034650313 hasLocation W20346503131 @default.
- W2034650313 hasLocation W20346503132 @default.
- W2034650313 hasOpenAccess W2034650313 @default.
- W2034650313 hasPrimaryLocation W20346503131 @default.
- W2034650313 hasRelatedWork W1531601525 @default.
- W2034650313 hasRelatedWork W2384123644 @default.
- W2034650313 hasRelatedWork W2385794720 @default.
- W2034650313 hasRelatedWork W2470947757 @default.
- W2034650313 hasRelatedWork W2518966398 @default.
- W2034650313 hasRelatedWork W2748952813 @default.
- W2034650313 hasRelatedWork W2899084033 @default.
- W2034650313 hasRelatedWork W2948807893 @default.
- W2034650313 hasRelatedWork W2778153218 @default.
- W2034650313 hasRelatedWork W3145608737 @default.
- W2034650313 hasVolume "132" @default.
- W2034650313 isParatext "false" @default.
- W2034650313 isRetracted "false" @default.
- W2034650313 magId "2034650313" @default.
- W2034650313 workType "article" @default.